Dr. Chung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
J2-2
Cleveland, OH 44195Phone+1 216-444-2290
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 1991 - 1993
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1990 - 1991
- Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 1986 - 1990
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1983 - 1986
- Washington University in St. Louis School of MedicineClass of 1983
Certifications & Licensure
- CA State Medical License 1987 - Present
- OH State Medical License 1993 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Clinical Cardiac Electrophysiology
Awards, Honors, & Recognition
- Fellow (FHRS) Heart Rhythm Society
- Fellow (FAHA) American Heart Association
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
- Join now to see all
Clinical Trials
- Identification of Genetic, Biochemical and Hormonal Factors Contributing to Atrial Fibrillation Start of enrollment: 2005 Aug 01
- Interventional Study of Anxiety Symptoms in the Implantable Cardioverter Defibrillator (ICD) Patient Start of enrollment: 2009 Feb 01
- Biospecimen Repository for Cardiac Arrhythmias at the Cleveland Clinic Start of enrollment: 2009 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Atrial Fibrillation: A Review.Darae Ko, Mina K Chung, Peter T Evans, Emelia J Benjamin, Robert H Helm
JAMA. 2024-12-16 - Upstream targeting for the prevention of atrial fibrillation: Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)-rationale and study design.Sojin Y Wass, John Barnard, Hyun Su Kim, Han Sun, William Telfer
Journal of Interventional Cardiac Electrophysiology. 2024-12-13 - Artificial Intelligence-Based Feature Analysis of Pulmonary Vein Morphology on Computed Tomography Scans and Risk of Atrial Fibrillation Recurrence After Catheter Abla...Golnoush Asaeikheybari, Majd El-Harasis, Amit Gupta, Ben B Shoemaker, John Barnard
Circulation. Arrhythmia and Electrophysiology. 2024-12-03
Journal Articles
- Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 PandemicHanad Bashir, Shameer Khubber, Khaled M Sleik, Mina K Chung, Umesh N Khot, Samir R Kapadia, JAMA Network Open
- Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Testing Positive for Coronavirus Disease 2019 (COVID-19)Andres E Carmona-Rubio, Miriam Jacob, Gary W Procop, Mina K Chung, JAMA Cardiology
- His Bundle PacingGaurav A Upadhyay, John D Fisher, Pugazhendhi Vijayaraman, Mina K Chung, George Crossley, Byron K Lee, Sanjeev Saksena, Gopi Dandamudi, Kousik Krishnan, ScienceDirect
- Join now to see all
Lectures
- Born to Be Bad: How Not to Miss a Clue in Family Member of Patient With SCD2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Connected and Wearable Technologies for Arrhythmia Management and Detection2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Pathogenesis of Sarcoidosis - What's Known? - Translational Talk2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Other
- Wearable cardioverter-defibrillatorChung MK
http://www.uptodate.com/contents/wearable-cardioverter-defibrillator
UpToDate, Wolters Kluwer Health - 2013-03-06
Authored Content
- Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 PandemicJuly 2020
- Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 PandemicJuly 2020
- Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 PandemicJuly 2020
- Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 PandemicJuly 2020
- Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 PandemicJuly 2020
- Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 PandemicJuly 2020
- Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 PandemicJuly 2020
- Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 PandemicJuly 2020
- Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Testing Positive for Coronavirus Disease 2019 (COVID-19)May 2020
- Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Testing Positive for Coronavirus Disease 2019 (COVID-19)May 2020
- Join now to see all
Press Mentions
- Metformin, Lifestyle Changes Fail to Reduce Afib BurdenNovember 20th, 2024
- Lifestyle & Risk Factor Changes Improved AFib Symptoms, Not Burden, over Standard CareNovember 18th, 2024
- Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AFNovember 18th, 2024
- Join now to see all
Committees
- member, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: